Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Penclomedine SCHEMBL29431894 | 1.00 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL10013346 | 0.81 | ABCB11 (0.35) | — | |
| SCHEMBL19841177 | 0.80 | — | — | |
| SCHEMBL2905410 | 0.80 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL7108425 | 0.78 | CYP1A2 (0.48) | CYP1A2 | |
| SCHEMBL13751437 | 0.76 | CUL4A (0.38) | — | |
| SCHEMBL13272289 | 0.69 | ABCB11 (0.30) | — | |
| SCHEMBL7944351 | 0.68 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL31277708 | 0.64 | KDM4E (0.35) | — | |
| SCHEMBL13880635 | 0.64 | KDM4E (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 551 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4640714-A2 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250275946-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2025-09-04 | — | — | US | claimed |
| EP-4177356-B1 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML SCREENING LLC (US) | 2024-05-08 | — | — | EP | claimed |
| US-20240082157-A1 | PREPARATION OF LIPOPHILIC ACTIVE INGREDIENTS | SPI PHARMA, INC. (US) | 2024-03-14 | — | — | US | claimed |
| EP-4177356-A1 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2023-05-10 | — | — | EP | claimed |
| US-11534375-B2 | Solvent-free method of encapsulating a hydrophobic active | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-12-27 | — | — | US | claimed |
| EP-3625368-B1 | METHODS FOR ASSESSING THE RISK OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY CAUSED BY JOHN CUNNINGHAM VIRUS BY GENETIC TESTING | PML SCREENING LLC (US) | 2022-11-09 | — | — | EP | claimed |
| WO-2022169634-A9 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2022-09-22 | — | — | WO | claimed |
| US-20220257772-A1 | PREPARATION OF LIPOPHILIC ACTIVE INGREDIENTS | SPI PHARMA, INC. (US) | 2022-08-18 | — | — | US | claimed |
| WO-2022169634-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2022-08-11 | — | — | WO | claimed |
| US-6207178-B1 | STABLE SUSPENSION | KABI PHARMACIA AB (SE) | 2001-03-27 | — | — | US | claimed |
| US-5785976-A | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof | PHARMACIA & UPJOHN AB (SE) | 1998-07-28 | — | — | US | claimed |
| EP-0711151-A1 | PARTICLES WITH MODIFIED PHYSICOCHEMICAL PROPERTIES, THEIR PREPARATION AND USES | KNOLL AKTIENGESELLSCHAFT (DE) | 1996-05-15 | — | — | EP | claimed |
| EP-0687172-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | Pharmacia & Upjohn Aktiebolag (SE) | 1995-12-20 | — | — | EP | claimed |
| WO-1995005164-A1 | PARTICLES WITH MODIFIED PHYSICOCHEMICAL PROPERTIES, THEIR PREPARATION AND USES | WESTESEN KIRSTEN (DE) | 1995-02-23 | — | — | WO | claimed |
| WO-1994020072-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | PHARMACIA AB (SE) | 1994-09-15 | — | — | WO | claimed |
| EP-0260524-B1 | 3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl) pyridine | DOW CHEMICAL CO (US) | 1994-01-05 | — | — | EP | claimed |
| WO-1992017162-A1 | LYOPHILIZED EMULSION | WARNER-LAMBERT COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0260524-A2 | 3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl) pyridine | THE DOW CHEMICAL COMPANY (US) | 1988-03-23 | — | — | EP | claimed |
| US-4717726-A | LEUKEMIA, LYMPHOMA, BREAST AND OVARIAN CANCER | THE DOW CHEMICAL COMPANY (US) | 1988-01-05 | — | — | US | claimed |